DCGI Urged To Withdraw Approval For Bharat Biotech’s Covaxin
New Delhi: The All India Drug Action Network (AIDAN) has urged the Drugs Controller General of India (DCGI) to reconsider the recommendations of the SEC in granting the REU approval to…